Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/176961
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Sequential bone marrow-cell delivery of VEGFA/S1P improves vascularization and limits adverse cardiac remodeling after myocardial infarction in mice |
Autor: | Zak, Magdalena M.; Gkontra, Polyxeni; Clemente, Cristina CSIC ORCID ; Squadrito, Mario Leonardo; Ferrarini, Alessia; Mota, Rubén A.; Oliver, Eduardo CSIC ORCID; Rocha, Susana; Agüero, Jaime; Vázquez, Jesús CSIC ORCID CVN; De Palma, Michele; Ibáñez, Borja; Arroyo, Alicia G. CSIC ORCID | Palabras clave: | VEGFA S1P Gene-cell angiotherapy Myocardial infarction Oxygen diffusion Cardiac remodeling |
Fecha de publicación: | 21-feb-2019 | Editor: | Mary Ann Liebert | Citación: | Human Gene Therapy 30 (7) 893-905 (2019) | Resumen: | Microvascular dysfunction and resulting tissue hypoxia is a major contributor to the pathogenesis and evolution of cardiovascular diseases (CVD). Diverse gene and cell therapies have been proposed to preserve the microvasculature or boost angiogenesis in CVD with moderate benefit. In this study, we tested in vivo the impact of sequential delivery by bone marrow cells of the pro-angiogenic factors vascular endothelial growth factor (VEGFA) and sphingosine-1-phosphate (S1P) in a myocardial infarction model. For that we transduced mouse bone marrow cells with lentiviral vectors coding for VEGFA or sphingosine kinase (SPHK1), which catalyzes S1P production, and injected them intravenously 4 and 7 days after cardiac ischemia/reperfusion in mice. Sequential delivery by transduced BM cells of VEGFA and S1P led to increased endothelial cell numbers and shorter extravascular distances in the infarct zone which support better oxygen diffusion 28 days post-MI as shown by automated 3D image analysis of the microvasculature. Milder effects were observed in the remote zone together with increased proportion of capillaries. BM cells delivering VEGFA and S1P also decreased myofibroblast abundance and restricted adverse cardiac remodeling without major impact on cardiac contractility. Our results indicate that BM cells engineered to sequentially deliver VEGFA/S1P angiogenic factors may constitute a promising strategy to improve micro-vascularization and oxygen diffusion thus limiting the adverse consequences of cardiac ischemia. | Descripción: | 29 p. main text and figure legends+ 20 p. figures and M&M | Versión del editor: | https://doi.org/10.1089/hum.2018.194 | URI: | http://hdl.handle.net/10261/176961 | DOI: | 10.1089/hum.2018.194 | ISSN: | 1043-0342 | E-ISSN: | 1557-7422 |
Aparece en las colecciones: | (CIB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Zak et al 2019 Human Gene Therapy Main Text, table and figure legends.pdf | Postprint | 629,41 kB | Adobe PDF | Visualizar/Abrir |
Zak et al 2019 Human Gene Therapy Figures, M&M.pdf | Figures and M&M | 2,44 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
9
checked on 20-abr-2024
WEB OF SCIENCETM
Citations
9
checked on 24-feb-2024
Page view(s)
294
checked on 23-abr-2024
Download(s)
210
checked on 23-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.